Literature DB >> 12709320

Functional similarities and differences between Candida albicans Cdr1p and Cdr2p transporters.

Christian Gauthier1, Sandra Weber, Anne-Marie Alarco, Omar Alqawi, Roni Daoud, Elias Georges, Martine Raymond.   

Abstract

The Candida albicans CDR1 and CDR2 genes code for highly homologous ATP-binding cassette (ABC) transporters which are overexpressed in azole-resistant clinical isolates and which confer resistance to multiple drugs by actively transporting their substrates out of the cells. These transporters are formed by two homologous halves, each with an intracellular domain containing an ATP-binding site followed by a membrane-associated domain. We have expressed Cdr1p and Cdr2p in Saccharomyces cerevisiae to investigate their functions. The two proteins were properly expressed and functional, as determined by Western blotting, drug susceptibility assays, and rhodamine efflux. Using total membrane proteins from these transformants, we showed that Cdr1p and Cdr2p bind to the photoreactive analogue of rhodamine 123, [(125)I]iodoaryl azido-rhodamine 123 (IAARh123). IAARh123 photoaffinity labeling of membranes prepared from cells expressing either the N half or the C half of Cdr2p, or both, demonstrated that both halves contribute to rhodamine binding and can bind to rhodamine independently. Interestingly, Cdr1p was found to confer hypersusceptibility to FK520, an immunosuppressant and antifungal agent, whereas Cdr2p conferred resistance to this compound, uncovering a major functional difference between the two transporters. Furthermore, when administered in combination with azoles, FK520 sensitized cells expressing CDR1 but not those expressing CDR2. Finally, we showed that Cdr2p confers hypersusceptibility to hydrogen peroxide and resistance to diamide, while Cdr1p has no effect against these oxidative agents. Taken together, our results demonstrate that, despite a high level of structural conservation, Cdr1p and Cdr2p exhibit major functional differences, suggesting distinct biological functions.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12709320      PMCID: PMC153331          DOI: 10.1128/AAC.47.5.1543-1554.2003

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  73 in total

1.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

2.  Calcineurin is essential for survival during membrane stress in Candida albicans.

Authors:  M Cristina Cruz; Alan L Goldstein; Jill R Blankenship; Maurizio Del Poeta; Dana Davis; Maria E Cardenas; John R Perfect; John H McCusker; Joseph Heitman
Journal:  EMBO J       Date:  2002-02-15       Impact factor: 11.598

3.  A common drug-responsive element mediates the upregulation of the Candida albicans ABC transporters CDR1 and CDR2, two genes involved in antifungal drug resistance.

Authors:  Michelle de Micheli; Jacques Bille; Christoph Schueller; Dominique Sanglard
Journal:  Mol Microbiol       Date:  2002-03       Impact factor: 3.501

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Identification of the multidrug resistance-related membrane glycoprotein as an acceptor for calcium channel blockers.

Authors:  A R Safa; C J Glover; J L Sewell; M B Meyers; J L Biedler; R L Felsted
Journal:  J Biol Chem       Date:  1987-06-05       Impact factor: 5.157

6.  ABC transporters Cdr1p, Cdr2p and Cdr3p of a human pathogen Candida albicans are general phospholipid translocators.

Authors:  S Krishnamurthy; B L Dixit; C M Gupta; S Milewski; R Prasad
Journal:  Yeast       Date:  2002-03-15       Impact factor: 3.239

7.  In vitro low-level resistance to azoles in Candida albicans is associated with changes in membrane lipid fluidity and asymmetry.

Authors:  Avmeet Kohli; Kasturi Mukhopadhyay; Ashok Rattan; Rajendra Prasad
Journal:  Antimicrob Agents Chemother       Date:  2002-04       Impact factor: 5.191

8.  Vanadate-catalyzed photocleavage of the signature motif of an ATP-binding cassette (ABC) transporter.

Authors:  Erin E Fetsch; Amy L Davidson
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-01       Impact factor: 11.205

9.  Transformation of intact yeast cells treated with alkali cations.

Authors:  H Ito; Y Fukuda; K Murata; A Kimura
Journal:  J Bacteriol       Date:  1983-01       Impact factor: 3.490

10.  ATP binding to the motor domain from an ABC transporter drives formation of a nucleotide sandwich dimer.

Authors:  Paul C Smith; Nathan Karpowich; Linda Millen; Jonathan E Moody; Jane Rosen; Philip J Thomas; John F Hunt
Journal:  Mol Cell       Date:  2002-07       Impact factor: 17.970

View more
  20 in total

1.  Fluconazole transport into Candida albicans secretory vesicles by the membrane proteins Cdr1p, Cdr2p, and Mdr1p.

Authors:  Luiz R Basso; Charles E Gast; Yuxin Mao; Brian Wong
Journal:  Eukaryot Cell       Date:  2010-03-26

2.  Beauvericin Potentiates Azole Activity via Inhibition of Multidrug Efflux, Blocks Candida albicans Morphogenesis, and Is Effluxed via Yor1 and Circuitry Controlled by Zcf29.

Authors:  Tanvi Shekhar-Guturja; Walters Aji Tebung; Harley Mount; Ningning Liu; Julia R Köhler; Malcolm Whiteway; Leah E Cowen
Journal:  Antimicrob Agents Chemother       Date:  2016-11-21       Impact factor: 5.191

3.  Positive regulation of the Candida albicans multidrug efflux pump Cdr1p function by phosphorylation of its N-terminal extension.

Authors:  Sarah Tsao; Sandra Weber; Christine Cameron; Dominic Nehme; Elaheh Ahmadzadeh; Martine Raymond
Journal:  J Antimicrob Chemother       Date:  2016-07-07       Impact factor: 5.790

4.  Synthetic Organotellurium Compounds Sensitize Drug-Resistant Candida albicans Clinical Isolates to Fluconazole.

Authors:  L F Reis de Sá; F T Toledo; A C Gonçalves; B A Sousa; A A Dos Santos; P F Brasil; V A Duarte da Silva; A C Tessis; J A Ramos; M A Carvalho; E Lamping; A Ferreira-Pereira
Journal:  Antimicrob Agents Chemother       Date:  2016-12-27       Impact factor: 5.191

5.  A proteomic approach to understanding the development of multidrug-resistant Candida albicans strains.

Authors:  H Kusch; K Biswas; S Schwanfelder; S Engelmann; P D Rogers; M Hecker; J Morschhäuser
Journal:  Mol Genet Genomics       Date:  2004-04-28       Impact factor: 3.291

6.  Rationally designed transmembrane peptide mimics of the multidrug transporter protein Cdr1 act as antagonists to selectively block drug efflux and chemosensitize azole-resistant clinical isolates of Candida albicans.

Authors:  Indresh Kumar Maurya; Chaitanya Kumar Thota; Sachin Dev Verma; Jyotsna Sharma; Manpreet Kaur Rawal; Balaguru Ravikumar; Sobhan Sen; Neeraj Chauhan; Andrew M Lynn; Virander Singh Chauhan; Rajendra Prasad
Journal:  J Biol Chem       Date:  2013-04-16       Impact factor: 5.157

7.  Identification of Nile red as a fluorescent substrate of the Candida albicans ATP-binding cassette transporters Cdr1p and Cdr2p and the major facilitator superfamily transporter Mdr1p.

Authors:  Irena Ivnitski-Steele; Ann R Holmes; Erwin Lamping; Brian C Monk; Richard D Cannon; Larry A Sklar
Journal:  Anal Biochem       Date:  2009-07-03       Impact factor: 3.365

8.  Relative contributions of the Candida albicans ABC transporters Cdr1p and Cdr2p to clinical azole resistance.

Authors:  Sarah Tsao; Fariba Rahkhoodaee; Martine Raymond
Journal:  Antimicrob Agents Chemother       Date:  2009-02-17       Impact factor: 5.191

Review 9.  Fungal PDR transporters: Phylogeny, topology, motifs and function.

Authors:  Erwin Lamping; Philippe V Baret; Ann R Holmes; Brian C Monk; Andre Goffeau; Richard D Cannon
Journal:  Fungal Genet Biol       Date:  2009-10-24       Impact factor: 3.495

10.  Characterization of three classes of membrane proteins involved in fungal azole resistance by functional hyperexpression in Saccharomyces cerevisiae.

Authors:  Erwin Lamping; Brian C Monk; Kyoko Niimi; Ann R Holmes; Sarah Tsao; Koichi Tanabe; Masakazu Niimi; Yoshimasa Uehara; Richard D Cannon
Journal:  Eukaryot Cell       Date:  2007-05-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.